C4 Therapeutics Inc. (NASDAQ: CCCC)
$3.6800
-0.0600 ( -0.81% ) 722.6K
C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.
Market Data
Open
$3.6800
Previous close
$3.7400
Volume
722.6K
Market cap
$264.00M
Day range
$3.5750 - $3.8090
52 week range
$3.3800 - $11.8800
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 15 | Jun 10, 2024 |
| 8-k | 8K-related | 15 | May 08, 2024 |
| 10-q | Quarterly Reports | 125 | May 08, 2024 |
| ars | Annual reports | 135 | Apr 30, 2024 |
| defa14a | Other | 13 | Apr 29, 2024 |
| def | Proxies and info statements | 23 | Apr 29, 2024 |
| 4 | Insider transactions | 1 | Apr 10, 2024 |
| sc | Insider transactions | 1 | Apr 10, 2024 |
| 4 | Insider transactions | 1 | Apr 02, 2024 |
| 4 | Insider transactions | 1 | Apr 02, 2024 |